Logo Privia Health Group, Inc.

Privia Health Group, Inc. (PRVA) stock: analyst price target and their real reliability

Live quote · data updated Oct 14, 2026
Privia Health Group, Inc. · Health Care · ref. ETF XLV · 56 calls · price $21.65
🔔Price alertsCreate an alert →
What the company does: Privia Health Group, Inc. operates as a national physician-enablement company in the United States.

📈 Privia Health Group, Inc. (PRVA) stock price

$21.65-12.7% over range
Oct 14, 25low $19.1 · high $28.1Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
50% recommend buying · 2 analysts
📊 JPI status : Privia Health Group, Inc. is no longer in our current JPI rankings, but appeared in the past (2024) — its upside may be behind it. See the stocks picked in 2024 →

🎯 PRVA price target & analyst consensus — price $21.65

The price target · all analysts combined (2 targets)
Highest target · 1 firm of 2$34+57.0%
Median target · of 2 targets$29+33.9%
Lowest target · 1 firm of 2$24+10.9%
Current price$21.65
⭐ What the most reliable analysts say

No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.

The consensus · 2 ratings (last 6 months)
Strong Buy00%
Buy150%
Hold150%
Sell00%
Strong Sell00%
Go deeper on the analysts
All analysts (the consensus)  ·  vs  ·  the best (those who've been right)
💬 A question about Privia Health Group, Inc.? The JPI assistant answers using our backtest data.

🔎 Detailed analyses

✅ Historical analyst reliability on PRVA

Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.

Firm ↕ % right i ↕ Gain vs sector i ↕ Calls i ↕
Evercore ISI Group ↗ 75% +6.7% 4
Baird ↗ 67% +9.8% 3
Stifel ↗ 50% +9.6% 2
Canaccord Genuity ↗ 50% -1.4% 8
RBC Capital ↗ 50% -2.0% 2
JMP Securities 50% -4.0% 4
Cowen & Co. 50% -7.6% 2
TD Cowen ↗ 50% -8.5% 2
Guggenheim ↗ 50% -12.8% 2
SVB Leerink 43% -1.1% 7
See the other 7 firms
Credit Suisse 14% -24.6% 7
Piper Sandler ↗ 33% -8.1% 3
UBS ↗ 33% -4.7% 3
Stephens & Co. ↗ 40% -4.2% 5
JP Morgan ↗ 40% -3.7% 5
Needham ↗ 40% +1.6% 5
Truist Securities ↗ 43% -3.1% 7

📊 What $1,000 invested in Privia Health Group, Inc. would be worth › open the full page

In short — $1,000 invested in Privia Health Group, Inc. 10 years ago would be worth $772 today, i.e. -5%/yr on average. Best year: 2025 (+18%), worst: 2024 (-13%). Price performance, excluding dividends.

If I'd invested $1,000 in Privia Health Group, Inc.

InvestmentWorth todayGain
1 years ago$1,404+40%
3 years ago$1,234+23%
5 years ago$772-23%
→ See Privia Health Group, Inc.'s full return history + gain calculator

Return by year (Privia Health Group, Inc.)

YearReturn$1,000 invested at year start
2026 (YTD)+19%$1,195 (+19%)
2025+18%$1,404 (+40%)
2024-13%$1,217 (+22%)
→ See Privia Health Group, Inc.'s full return history + gain calculator
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

📰 Recent news on Privia Health Group, Inc.

Loading news…

📋 All analyst calls on PRVA

Barclays ↗
May 26, 26
■ Equal-Weight neutral · not a buy · 🎯$24
Price at call : $21.74 — gap to target +10%
Today : $21.65 — gap to target +11%
🎯 on PRVA : no call matured yet · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : May 26, 27
▲ Buy · 🎯$34
Price at call : $22.76 — upside +49%
Today : $21.65 — upside +57%
🎯 on PRVA : 50% (8 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
in progress (365j)
matures : May 9, 27
▲ Outperform · 🎯$26
Price at call : $22.71 — upside +14%
Today : $21.65 — upside +20%
🎯 on PRVA : 100% (2 calls matureds) · 📊 on Health : 36.4% · -8.5% (33 calls)
in progress (365j)
matures : Apr 8, 27
Barclays ↗
Mar 25, 26
■ Equal-Weight neutral · not a buy · 🎯$25
Price at call : $20.54 — gap to target +22%
Today : $21.65 — gap to target +15%
🎯 on PRVA : no call matured yet · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : Mar 25, 27
Citigroup ↗
Mar 3, 26
▲ Buy · 🎯$32
Price at call : $24.3 — upside +32%
Today : $21.65 — upside +48%
🎯 on PRVA : no call matured yet · 📊 on Health : 44.9% · -4.4% (107 calls)
in progress (365j)
matures : Mar 3, 27
▲ Buy · 🎯$33
Price at call : $24.04 — upside +37%
Today : $21.65 — upside +52%
🎯 on PRVA : 67% (3 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Mar 2, 27
▲ Buy · 🎯$35
Price at call : $24.04 — upside +46%
Today : $21.65 — upside +62%
🎯 on PRVA : 50% (8 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
in progress (365j)
matures : Feb 27, 27
▲ Overweight · 🎯$32
Price at call : $24 — upside +33%
Today : $21.65 — upside +48%
🎯 on PRVA : 50% (4 calls matureds) · 📊 on Health : 44.3% · +2.1% (88 calls)
in progress (365j)
matures : Dec 4, 26
See the other 48 calls, newest to oldest
JP Morgan ↗
Nov 13, 25
▲ Overweight · 🎯$33
Price at call : $23.45 — upside +41%
Today : $21.65 — upside +52%
🎯 on PRVA : 50% (2 calls matureds) · 📊 on Health : 49% · +6.7% (149 calls)
in progress (365j)
matures : Nov 13, 26
BMO Capital ↗
Nov 13, 25
▲ Outperform · 🎯$30
Price at call : $23.75 — upside +26%
Today : $21.65 — upside +39%
🎯 on PRVA : no call matured yet · 📊 on Health : 43.3% · -2.2% (67 calls)
in progress (365j)
matures : Nov 13, 26
▲ Buy · 🎯$34
Price at call : $24.22 — upside +40%
Today : $21.65 — upside +57%
🎯 on PRVA : 50% (8 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
in progress (365j)
matures : Nov 12, 26
Barclays ↗
Nov 10, 25
■ Equal-Weight neutral · not a buy · 🎯$23
Price at call : $24.32 — gap to target -5%
Today : $21.65 — gap to target +6%
🎯 on PRVA : no call matured yet · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : Nov 10, 26
▲ Buy · 🎯$31
Price at call : $24.32 — upside +27%
Today : $21.65 — upside +43%
🎯 on PRVA : 67% (3 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Nov 10, 26
▲ Outperform · 🎯$30
Price at call : $23.41 — upside +28%
Today : $21.65 — upside +39%
🎯 on PRVA : 100% (2 calls matureds) · 📊 on Health : 36.4% · -8.5% (33 calls)
in progress (365j)
matures : Nov 7, 26
Citizens
Nov 7, 25
▲ Market Outperform · 🎯$31
Price at call : $23.43 — upside +32%
Today : $21.65 — upside +43%
🎯 on PRVA : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Nov 7, 26
Barclays ↗
Oct 9, 25
■ Equal-Weight neutral · not a buy · 🎯$22
Price at call : $24.2 — gap to target -9%
Today : $21.65 — gap to target +2%
🎯 on PRVA : no call matured yet · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : Oct 9, 26
Stephens & Co. ↗
Sep 24, 25
▲ Overweight · 🎯$32
Price at call : $23.34 — upside +37%
Today : $21.65 — upside +48%
Expected +37% · Actual -17% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 50% (4 calls matureds) · 📊 on Health : 44.3% · +2.1% (88 calls)
-16.9%
stock -17% · XLV +25%
matured Sep 24, 26
▲ Overweight · 🎯$32
Price at call : $23.12 — upside +38%
Today : $21.65 — upside +48%
Expected +38% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 50% (4 calls matureds) · 📊 on Health : 44.3% · +2.1% (88 calls)
-10.6%
stock -11% · XLV +25%
matured Sep 4, 26
JMP Securities
Aug 29, 25
▲ Market Outperform · 🎯$30
Price at call : $23.19 — upside +29%
Today : $21.65 — upside +39%
Expected +29% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 33% (3 calls matureds) · 📊 unranked overall
-11.6%
stock -12% · XLV +24%
matured Aug 29, 26
Piper Sandler ↗
Aug 11, 25
▲ Overweight · 🎯$35
Price at call : $20.31 — upside +72%
Today : $21.65 — upside +62%
Expected +72% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 50% (2 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
+8.2%
stock +8% · XLV +29%
matured Aug 11, 26
▲ Outperform · 🎯$28
Price at call : $21.2 — upside +32%
Today : $21.65 — upside +29%
Expected +32% · Actual +31% · Reason (≥ +15%) : ✓ Yes
🎯 on PRVA : 100% (2 calls matureds) · 📊 on Health : 36.4% · -8.5% (33 calls)
+31.0%
stock +31% · XLV +20%
matured Jul 9, 26
JP Morgan ↗
May 28, 25
▲ Overweight · 🎯$32
Price at call : $22.55 — upside +42%
Today : $21.65 — upside +48%
Expected +42% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 50% (2 calls matureds) · 📊 on Health : 49% · +6.7% (149 calls)
-4.6%
stock -5% · XLV +13%
matured May 28, 26
Barclays ↗
May 27, 25
■ Equal-Weight neutral · not a buy · 🎯$24
Price at call : $23.07 — gap to target +4%
Today : $21.65 — gap to target +11%
🎯 on PRVA : no call matured yet · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : May 27, 26
JMP Securities
Apr 28, 25
▲ Market Outperform · 🎯$29
Price at call : $23.41 — upside +24%
Today : $21.65 — upside +34%
Expected +24% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 33% (3 calls matureds) · 📊 unranked overall
+5.5%
stock +5% · XLV +3%
matured Apr 28, 26
Baird ↗
Apr 15, 25
▲ Outperform · 🎯$26
Price at call : $24.19 — upside +7%
Today : $21.65 — upside +20%
Expected +7% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 67% (3 calls matureds) · 📊 on Health : 38.1% · -2.9% (84 calls)
-3.1%
stock -3% · XLV +7%
matured Apr 15, 26
Barclays ↗
Apr 10, 25
■ Equal-Weight neutral · not a buy · 🎯$23
Price at call : $24.1 — gap to target -5%
Today : $21.65 — gap to target +6%
🎯 on PRVA : no call matured yet · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : Apr 10, 26
▲ Buy · 🎯$28
Price at call : $23.65 — upside +18%
Today : $21.65 — upside +29%
Expected +18% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 67% (3 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
-5.4%
stock -5% · XLV +9%
matured Apr 10, 26
Needham ↗
Apr 10, 25
▲ Buy · 🎯$30
Price at call : $23.65 — upside +27%
Today : $21.65 — upside +39%
Expected +27% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 40% (5 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
-5.4%
stock -5% · XLV +9%
matured Apr 10, 26
Needham ↗
Mar 21, 25
▲ Buy · 🎯$30
Price at call : $23.34 — upside +29%
Today : $21.65 — upside +39%
Expected +29% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 40% (5 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
-7.8%
stock -8% · XLV -1%
matured Mar 21, 26
▲ Market Outperform · 🎯$29
Price at call : $24.96 — upside +16%
Today : $21.65 — upside +34%
Expected +16% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 0% (1 call matured) · 📊 unranked overall
-3.7%
stock -4% · XLV +6%
matured Feb 28, 26
▲ Buy · 🎯$30
Price at call : $24.96 — upside +20%
Today : $21.65 — upside +39%
Expected +20% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 50% (8 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
-3.7%
stock -4% · XLV +6%
matured Feb 28, 26
Piper Sandler ↗
Feb 28, 25
▲ Overweight · 🎯$40
Price at call : $24.97 — upside +60%
Today : $21.65 — upside +85%
Expected +60% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 50% (2 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
-3.7%
stock -4% · XLV +6%
matured Feb 28, 26
Needham ↗
Feb 28, 25
▲ Buy · 🎯$30
Price at call : $24.97 — upside +20%
Today : $21.65 — upside +39%
Expected +20% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 40% (5 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
-3.7%
stock -4% · XLV +6%
matured Feb 28, 26
JMP Securities
Feb 14, 25
▲ Market Outperform · 🎯$26
Price at call : $25.04 — upside +4%
Today : $21.65 — upside +20%
Expected +4% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 33% (3 calls matureds) · 📊 unranked overall
-11.8%
stock -12% · XLV +9%
matured Feb 14, 26
Needham ↗
Jan 15, 25
▲ Buy · 🎯$25
Price at call : $21.57 — upside +16%
Today : $21.65 — upside +15%
Expected +16% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 40% (5 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
+10.6%
stock +11% · XLV +12%
matured Jan 15, 26
Needham ↗
Jan 10, 25
▲ Buy · 🎯$25
Price at call : $20.51 — upside +22%
Today : $21.65 — upside +15%
Expected +22% · Actual +14% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 40% (5 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
+14.2%
stock +14% · XLV +13%
matured Jan 10, 26
▲ Overweight · 🎯$26
Price at call : $20.3 — upside +28%
Today : $21.65 — upside +20%
Expected +28% · Actual +19% · Reason (≥ +15%) : ✓ Yes
🎯 on PRVA : 50% (4 calls matureds) · 📊 on Health : 44.3% · +2.1% (88 calls)
+19.2%
stock +19% · XLV +14%
matured Jan 7, 26
▲ Overweight · 🎯$26
Price at call : $19.64 — upside +32%
Today : $21.65 — upside +20%
Expected +32% · Actual +19% · Reason (≥ +15%) : ✓ Yes
🎯 on PRVA : 50% (4 calls matureds) · 📊 on Health : 44.3% · +2.1% (88 calls)
+19.4%
stock +19% · XLV +13%
matured Jan 2, 26
Macquarie ↗
Dec 16, 24
▲ Outperform · 🎯$25
Price at call : $21.87 — upside +14%
Today : $21.65 — upside +15%
Expected +14% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 100% (1 call matured) · 📊 on Health : 40% · +4.7% (10 calls)
+8.9%
stock +9% · XLV +11%
matured Dec 16, 25
JP Morgan ↗
Nov 29, 24
▲ Overweight · 🎯$28
Price at call : $22.31 — upside +26%
Today : $21.65 — upside +29%
Expected +26% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 50% (2 calls matureds) · 📊 on Health : 49% · +6.7% (149 calls)
+8.0%
stock +8% · XLV +6%
matured Nov 29, 25
Barclays ↗
Nov 8, 24
■ Equal-Weight neutral · not a buy · 🎯$21
Price at call : $22.8 — gap to target -8%
Today : $21.65 — gap to target -3%
🎯 on PRVA : no call matured yet · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : Nov 8, 25
▲ Buy · 🎯$27
Price at call : $22.8 — upside +18%
Today : $21.65 — upside +25%
Expected +18% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 67% (3 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
+2.7%
stock +3% · XLV -1%
matured Nov 8, 25
Keybanc ↗
Oct 11, 24
▲ Overweight · 🎯$23
Price at call : $17.76 — upside +30%
Today : $21.65 — upside +6%
Expected +30% · Actual +36% · Reason (≥ +15%) : ✓ Yes
🎯 on PRVA : 100% (1 call matured) · 📊 on Health : 23.6% · -18.3% (110 calls)
+35.9%
stock +36% · XLV -8%
matured Oct 11, 25
Baird ↗
Aug 26, 24
▲ Outperform · 🎯$24
Price at call : $21.29 — upside +13%
Today : $21.65 — upside +11%
Expected +13% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 67% (3 calls matureds) · 📊 on Health : 38.1% · -2.9% (84 calls)
+0.5%
stock +0% · XLV -12%
matured Aug 26, 25
RBC Capital ↗
Aug 14, 24
▲ Outperform · 🎯$28
Price at call : $19.53 — upside +43%
Today : $21.65 — upside +29%
Expected +43% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 100% (1 call matured) · 📊 on Health : 31.1% · -10.5% (167 calls)
+8.9%
stock +9% · XLV -11%
matured Aug 14, 25
▲ Outperform · 🎯$20
Price at call : $17.11 — upside +17%
Today : $21.65 — upside -8%
Expected +17% · Actual +23% · Reason (≥ +15%) : ✓ Yes
🎯 on PRVA : 100% (2 calls matureds) · 📊 on Health : 36.4% · -8.5% (33 calls)
+23.3%
stock +23% · XLV -7%
matured Jul 9, 25
Baird ↗
May 30, 24
▲ Outperform · 🎯$23
Price at call : $17.26 — upside +33%
Today : $21.65 — upside +6%
Expected +33% · Actual +32% · Reason (≥ +15%) : ✓ Yes
🎯 on PRVA : 67% (3 calls matureds) · 📊 on Health : 38.1% · -2.9% (84 calls)
+31.9%
stock +32% · XLV -6%
matured May 30, 25
Barclays ↗
May 20, 24
■ Equal-Weight neutral · not a buy · 🎯$19
Price at call : $16.15 — gap to target +18%
Today : $21.65 — gap to target -12%
🎯 on PRVA : no call matured yet · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : May 20, 25
▲ Buy · 🎯$24
Price at call : $17 — upside +41%
Today : $21.65 — upside +11%
Expected +41% · Actual +47% · Reason (≥ +15%) : ✓ Yes
🎯 on PRVA : 67% (3 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
+47.2%
stock +47% · XLV -9%
matured May 15, 25
▲ Buy · 🎯$26
Price at call : $17.99 — upside +45%
Today : $21.65 — upside +20%
Expected +45% · Actual +39% · Reason (≥ +15%) : ✓ Yes
🎯 on PRVA : 50% (8 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
+39.3%
stock +39% · XLV -5%
matured May 10, 25
▲ Buy · 🎯$37
Price at call : $20.88 — upside +77%
Today : $21.65 — upside +71%
Expected +77% · Actual +13% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 50% (8 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
+13.2%
stock +13% · XLV +1%
matured Mar 19, 25
▲ Buy · 🎯$43
Price at call : $26.84 — upside +60%
Today : $21.65 — upside +99%
Expected +60% · Actual -21% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 50% (8 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
-20.7%
stock -21% · XLV -5%
matured Nov 11, 23
▲ Buy · 🎯$50
Price at call : $39.01 — upside +28%
Today : $21.65 — upside +131%
Expected +28% · Actual -35% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 50% (8 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
-34.6%
stock -35% · XLV +5%
matured Aug 25, 23
▲ Buy · 🎯$29
Price at call : $22.78 — upside +27%
Today : $21.65 — upside +34%
Expected +27% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on PRVA : 50% (8 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
+15.6%
stock +16% · XLV +2%
matured May 13, 23
▲ Buy · 🎯$44
Price at call : $25.65 — upside +72%
Today : $21.65 — upside +103%
Expected +72% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 50% (8 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
+8.1%
stock +8% · XLV -6%
matured Mar 24, 23
▲ Buy · 🎯$47
Price at call : $32.32 — upside +45%
Today : $21.65 — upside +117%
Expected +45% · Actual -29% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 50% (8 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
-28.7%
stock -29% · XLV +5%
matured May 24, 22

Frequently asked questions

Should I buy Privia Health Group, Inc. stock?

This isn't buy advice. For Privia Health Group, Inc., the analyst consensus is "Buy", with an average price target of $29.00 (+34% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 75% of the time (4 calls tracked on Privia Health Group, Inc.). We show the numbers — you decide.

Is it too late to buy Privia Health Group, Inc.? How high can it go?

The most bullish analyst target on Privia Health Group, Inc. is $34.00 (+57% above today's price); the average is $29.00. That's the upside they see. Check how reliable those analysts have actually been on Privia Health Group, Inc. on our site before trusting it.

Is Privia Health Group, Inc. still a good buy?

The most useful "opinion" isn't an opinion — it's a track record: 17 analysts have a real record on Privia Health Group, Inc., the best hitting 75% over 4 calls. Current consensus: "Buy". Make your call on data, not noise.

What has Privia Health Group, Inc.'s past performance been?

Historical returns and a "how much if I had invested" calculator: PRVA performance & returns.

Other Health stocks

Go further

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)